The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. AAPL
2. BRZE
3. TTAN
4. CHYM
5. USO
6. COO
7. QCOM
8. IRT
9. AEO
10. MSI

Go back to The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program
(NASDAQ: AUPH) Delayed: 16.25 +0.18 (1.12%)
Previous Close $16.07    52 Week High $5.69 
Open $15.97    52 Week Low $1.42 
Day High $16.32    P/E N/A 
Day Low $15.85    EPS $0.00 
Volume 723,296